Back to the main directory
EarningsReview / Equity
- XXL (Buy, TP: NOK12.00) - Q2 profit warning by DnB Markets
- Komplett (Buy, TP: NOK45.00) - Sailing in rough waters by DnB Markets
- Jm Ab (No_rec, TP: SEK) - Recommendation and target price withdrawn by DnB Markets
- Alfa Laval (Buy, TP: SEK300.00) - We like Marine, we like Energy by DnB Markets
- Hennes & Mauritz Minor model adjustments by DnB Markets
- IRLAB Therapeutics - Screening platform continues to bear fruit by Edison Investment Research
- Quadrise Fuels International - Moving forward in Morocco by Edison Investment Research
- Royal Mail (RMG LN) by HSBC
- Investment Daily 16/06/2022 by BNP Paribas Exane
- EQUITA SIM: OVS (BUY; Unchanged): 1Q22 Results by Equita Sim
- Inflation strikes back by BNP Paribas Exane
- CMD postview: No big bang, but quiet confidence by BNP Paribas Exane
- Byggfakta Group (Buy, TP: SEK61.00) - Double-digit FCF yield prospects by DnB Markets
- Ericsson (Buy, TP: SEK125.00) - Resilient earnings by DnB Markets
- Games Workshop Group - Strong revenue growth and royalties income by Edison Investment Research
- Day 3 - Tweets and Quotes by BNP Paribas Exane
- EU carbon market reform progress by BNP Paribas Exane
- The Good, The Bad And The MandA by BNP Paribas Exane
- Investment Daily 17/06/2022 by BNP Paribas Exane
- INVEST SECURITIES - OSE IMMUNO : Stratégie multiproduits, un atout dans le contexte - ACHAT, OC 14,3€ by Invest Securities
- Trustpilot - CMD supports our positive view by Danske Bank Equity Research
- Hexpol (Buy, TP: SEK114.00) - Automotive recovery ahead by DnB Markets
- CLIQ Digital - Strategic update and financials upgrade by Edison Investment Research
- Henderson International Income Trust - Inflation-beating dividend growth by Edison Investment Research
- Eneti Inc - Initiation of coverage - Benefiting from green tailwinds by DnB Markets
- Aker Biomarine (Hold, TP: NOK54.00) - Krilling me softly by DnB Markets
- SBB Norden (No_rec, TP: SEK) - Recommendation and target price withdrawn by DnB Markets
- Arjo (Buy, TP: SEK110.00) - Q2 set to be in line with guidance by DnB Markets
- Getinge (Buy, TP: SEK370.00) - Profit warning for 2022 by DnB Markets
- Accsys Technologies - Additional capacity comes at additional costs by Edison Investment Research
- IRLAB Therapeutics - Richard Godfrey appointed as new CEO by Edison Investment Research
- Ultimovacs - Patient enrolment continues; catalysts approach by Edison Investment Research
- Day 2 - Tweets and Quotes by BNP Paribas Exane
- Strong start to the year by BNP Paribas Exane
- 中国交运物流行业 by HSBC
- Randall & Quilter - FY21 Results Quick Take - Jun 22 by Capital Access Group
- HMS Networks (Hold, TP: SEK460.00) - Strong Q2 report ahead by DnB Markets
- Swedish Orphan Biovitrum (Buy, TP: SEK265.00) - Healthy quarter expected by DnB Markets
- AFT Pharmaceuticals - Re-acceleration leveraging its platform by Edison Investment Research
- IP Group - Impact + innovation at a compelling discount by Edison Investment Research
- CMD review: revenue synergies and customer tributes by BNP Paribas Exane
- Business transformation is progressing well by BNP Paribas Exane
- Investor day feedback by BNP Paribas Exane
- EQUITA SIM: SAES GETTERS (BUY ord.; Prev. HOLD - BUY sav. ; prev. HOLD) - Roadshow feedback by Equita Sim
- INVEST SECURITIES - DASSAULT SYSTEMES : Le seul problème c'est le derating de la Tech - NEUTRE, OC 32€ vs 36€ by Invest Securities
- Betsson (Buy, TP: SEK80.00) - A unique strategy for growth by DnB Markets
- Hexagon AB (Buy, TP: SEK143.00) - Positive trends set to continue by DnB Markets
- discoverIE Group - Strong growth despite market challenges by Edison Investment Research
- InMed Pharmaceuticals - THCV launch expands rare cannabinoids portfolio by Edison Investment Research
- Volvo Cars (Sell, TP: SEK62.00) - Our data shows falling demand by DnB Markets